Barclays initiated coverage with a $350 target and compared IBM’s quantum computing position to Nvidia’s GPU dominance, while a recirculating Trump clip adds retail momentum
IBM stock surged 10% after Barclays initiated coverage with an overweight rating and $350 target, arguing that IBM’s infrastructure software is the “good part” of enterprise software immune to AI disruption. The gains extend a 30% May rally driven by a $10 billion quantum computing commitment and Trump administration funding.TL;DR
IBM stock surged 10% on Monday after Barclays initiated coverage with an overweight rating and a $350 price target, roughly 11% above the opening price. The jump extends a run that has seen IBM gain nearly 30% in May alone, its best monthly performance in almost 24 years. The stock is now up 10% year to date, erasing losses from the SaaSpocalypse selloff that hit software stocks earlier in the year.
Barclays’ bull case is not primarily about quantum computing, though that features prominently. The core thesis centres on IBM’s infrastructure software portfolio, which serves large, heavily regulated enterprises and generates the majority of the company’s profit. In a market where vibe coding and AI agents are threatening horizontal SaaS companies, Barclays argues that IBM’s type of software, deeply embedded infrastructure tools, is precisely the category least vulnerable to disruption.
“While software has a negative investor connotation at the moment, IBM is offering infrastructure software (the good part) to large, often heavily regulated customers, which creates a very sticky set-up that should not see negative AI implications,” the analysts wrote. They expect mid-single-digit organic revenue growth and ongoing margin expansion, describing IBM as “a stable earnings compounder with a Quantum option.”
The distinction matters. The SaaSpocalypse punished software stocks indiscriminately, but the companies most exposed are those selling horizontal tools, project management, CRM, form builders, that AI can replicate. IBM’s software business, which includes middleware, database management, and enterprise integration platforms, sits at the infrastructure layer where switching costs are measured in years and compliance requirements create natural moats.
In their most optimistic bull case, Barclays set a price target of $449, representing 51% upside from the last close.
Barclays framed IBM’s quantum computing ambitions as additional upside rather than the primary investment thesis. “Quantum computing has the potential to become the next major compute paradigm, following the CPU and GPU eras,” the analysts wrote, comparing IBM’s positioning in quantum to Nvidia’s dominance in GPUs. Quantinuum’s massively oversubscribed IPO last week demonstrated that investor appetite for quantum exposure is running hot.
IBM has committed $10 billion to quantum computing over the next five years, according to a regulatory filing disclosed last week. The centrepiece is Anderon, a standalone quantum chip foundry headquartered in Albany, New York, built with $1 billion from the US Department of Commerce under the CHIPS Act and a matching $1 billion from IBM. Anderon will operate the first purpose-built 300-millimetre quantum wafer fabrication facility in the United States.
The Commerce Department’s $2 billion quantum portfolio, split across nine companies and announced on 21 May, is the largest single quantum R&D commitment in US history. IBM received the largest share. Smaller firms including D-Wave Quantum, Rigetti Computing, and their European counterparts are pursuing different quantum architectures with their own government backing.
Adding a distinctly 2026 element to the rally is a video of President Trump from a December 2025 White House business roundtable, which has been recirculating on X and Reddit. Trump called IBM CEO Arvind Krishna “a legend” and said, “He’s taken the stock from a rather low price to a very nice price. I won’t say high because I’m sure you’re going to say it’s going to go up a lot more, right?”
Social media posts framed the clip as Trump endorsing IBM stock. Trump’s personal investment account has purchased IBM shares in recent months, according to Office of Government Ethics filings. The combination of a presidential mention, visible government support through the quantum funding programme, and a Barclays initiation has created a momentum loop that draws both institutional and retail interest simultaneously.
IBM’s recent gains fit into a broader pattern of legacy computing companies finding new relevance in the AI era. Dell’s stock surged 32% last week on AI server demand. Cisco, once a dot-com era cautionary tale, has rallied on enterprise networking demand driven by AI infrastructure buildouts. IBM’s version of the story combines two threads: a software business that is defensible against AI disruption, and a quantum computing programme that could become transformative if the technology matures on schedule.
Whether the quantum option alone justifies the current run is debatable. IBM’s quantum programme is real and well-funded, but commercial quantum computing remains years away from generating meaningful revenue. Barclays is explicit that the investment case rests on the software business today and quantum as future upside. For investors burned by the SaaSpocalypse, the appeal of a software company whose customers cannot easily leave, and whose product category AI makes more valuable rather than obsolete, is straightforward.
Get the most important tech news in your inbox each week.
